【第39期：分析AR_老虎社区_美港股上老虎

艾达财经
2020-12-21

【第39期：分析ARKG! 新建仓了一只新上市的医疗股：MASS！】本周重点介绍了遗传领域的创新基金，ARKG，发现基金本周频繁操作医疗类股票，所以引起关注。二是重点介绍了增持的5只股票，薛定谔，SDGR，诺华制药，NVS，爱奥尼斯制药，IONS，武田制药，TAK和表面肿瘤学，SURF，此外还新建仓一只新股，MASS。

# 追踪ARK女神

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":330393975,"tweetId":"330393975","gmtCreate":1608534160093,"gmtModify":1703735215565,"author":{"id":3570625982426607,"idStr":"3570625982426607","authorId":3570625982426607,"authorIdStr":"3570625982426607","name":"艾达财经","avatar":"https://static.tigerbbs.com/cc7b129b0b3f9754d63a848f85e11dfd","vip":8,"userType":8,"introduction":"专注方舟基金ARKK，ARKW，ARKG等美股分析","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4241,"starInvestorFlag":false},"themes":[{"themeId":"258552fe880d444a8ceedf02b1969a86","categoryId":"bc7f9e79615545918dda2e7d7cfb9e15","name":"追踪ARK女神","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":258552fe880d444a8ceedf02b1969a86}&rnconfig={\"headerBarHidden\": true}","description":"Catherine Wood于2013年创办方舟投资管理公司。她的投资绩效非常突出，一起追踪ARK持仓~","image":"https://static.tigerbbs.com/a9e2e5103e0734663e9364cb0c8fe152"}],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>【第39期：分析ARKG! 新建仓了一只新上市的医疗股：MASS！】本周重点介绍了遗传领域的创新基金，ARKG，发现基金本周频繁操作医疗类股票，所以引起关注。 二是重点介绍了增持的5只股票，薛定谔，SDGR， 诺华制药，NVS，爱奥尼斯制药，IONS， 武田制药，TAK和表面肿瘤学，SURF，此外还新建仓一只新股，MASS。</p></body></html>","htmlText":"<html><head></head><body><p>【第39期：分析ARKG! 新建仓了一只新上市的医疗股：MASS！】本周重点介绍了遗传领域的创新基金，ARKG，发现基金本周频繁操作医疗类股票，所以引起关注。 二是重点介绍了增持的5只股票，薛定谔，SDGR， 诺华制药，NVS，爱奥尼斯制药，IONS， 武田制药，TAK和表面肿瘤学，SURF，此外还新建仓一只新股，MASS。</p></body></html>","text":"【第39期：分析ARKG! 新建仓了一只新上市的医疗股：MASS！】本周重点介绍了遗传领域的创新基金，ARKG，发现基金本周频繁操作医疗类股票，所以引起关注。 二是重点介绍了增持的5只股票，薛定谔，SDGR， 诺华制药，NVS，爱奥尼斯制药，IONS， 武田制药，TAK和表面肿瘤学，SURF，此外还新建仓一只新股，MASS。","highlighted":1,"essential":2,"paper":1,"likeSize":18,"commentSize":0,"repostSize":4,"favoriteSize":0,"link":"https://laohu8.com/post/330393975","repostId":0,"isVote":1,"tweetType":2,"object":{"id":"99a056131eb244daab512d648d83efd9","videoUrl":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/e44074d05285890811547357751/FV6gXQEFHhEA.mp4","poster":"https://static.tigerbbs.com/1761a15d09ed2ec2850c155e7cfcc103","desc":""},"viewCount":13114,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["SURF","IONS","NVS","SDGR"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":259,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}